SBIR-STTR Award

Host-Targeted Antiviral Drugs Providing Rapid, Scalable, Stable, Broad-Spectrum MedicalCountermeasure Against Marburg Virus
Award last edited on: 2/6/21

Sponsored Program
STTR
Awarding Agency
DOD : CBD
Total Award Amount
$149,997
Award Phase
1
Solicitation Topic Code
CBD18A-002
Principal Investigator
Stacy W Remiszewski

Company Information

Evrys Bio LLC (AKA: Forge Life Sciences LLC)

3805 Old Easton Road
Doylestown, PA 18902
   (267) 893-6755
   business@evrysbio.com
   www.forgelifescience.com

Research Institution

Baruch S Blumberg Institute

Phase I

Contract Number: W911QY-18-P-0300
Start Date: 9/25/18    Completed: 3/25/19
Phase I year
2018
Phase I Amount
$149,997
In a pandemic or exposure to weaponized Marburg virus the morbidity, mortality and social unrest that will ensue before vaccines orMilitary operating on foreign soil as well as to the population of the US Homeland. Practically all threat agents of biological origin (except forcertain non-proteinaceous toxins, typically produced by marine organisms and fungi) have their structure and vital function intimatelyintertwined with highly characteristic protein molecules. Detection and characterization of these signature protein molecules can provide anextremely accurate approach to the detection of the threat agents. We propose to develop, prototype and validate a field-portable massspectrometer with associated disposable cartridges for biothreat agents. The system will be capable of detecting all classes of biothreat agentsin cluttered sample matrices. The disposable cartridge will be used to prepare the sample for analysis in the spectrometer. The system isanticipated to have an analysis time of less than 5 minutes and will have a cost per sample of less than $20.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----